CJC-1295 (no DAC)vsMelatonin

CJC-1295 (no DAC), also known as Mod GRF 1-29, is a synthetic analogue of the first 29 amino acids of growth hormone-releasing hormone (GHRH). Four amino acid substitutions (at positions 2, 8, 15, and 27) have been made to increase resistance to enzymatic degradation while preserving full biological activity at the GHRH receptor (GHRH-R), a G protein-coupled receptor expressed on somatotroph cells in the anterior pituitary.

When CJC-1295 binds the GHRH receptor, it activates the Gs alpha subunit, which stimulates adenylyl cyclase to produce cyclic AMP (cAMP). Rising cAMP levels activate protein kinase A (PKA), which phosphorylates CREB (cAMP response element-binding protein) and other transcription factors that drive GH gene expression and secretion. Importantly, this mechanism preserves the natural pulsatile pattern of GH release because it works within the existing hypothalamic-pituitary feedback loop — somatostatin still provides inhibitory regulation between pulses.

The key advantage of the no-DAC version over the DAC version is this preservation of pulsatility. Because its half-life is approximately 30 minutes, it produces a discrete GH pulse that rises and falls naturally, mimicking the body's own secretory pattern. This pulsatile pattern is believed to be physiologically superior to sustained elevation because GH receptor sensitivity is maintained between pulses, and the liver's IGF-1 production response is optimized by intermittent rather than continuous GH stimulation. This is why CJC-1295 (no DAC) is often preferred by practitioners despite requiring more frequent dosing.

Melatonin (N-acetyl-5-methoxytryptamine) is synthesized in the pineal gland from serotonin through a two-step pathway: N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin, and hydroxyindole O-methyltransferase (HIOMT) converts it to melatonin. AANAT activity is under direct control of the suprachiasmatic nucleus (SCN) master circadian clock — it is strongly suppressed by light (via the retinohypothalamic tract) and activated in darkness, creating the characteristic nocturnal melatonin surge that signals nighttime to every cell in the body.

Melatonin acts through two high-affinity G protein-coupled receptors: MT1 (MTNR1A) and MT2 (MTNR1B), both of which are Gi/o-coupled, inhibiting adenylyl cyclase and reducing cAMP when activated. MT1 receptors in the SCN mediate the acute sleep-promoting effect — their activation inhibits the firing rate of SCN neurons, reducing the alerting signal from the master clock and promoting sleepiness. MT2 receptors in the SCN mediate circadian phase-shifting — their activation during the biological evening advances the clock phase (useful for jet lag and delayed sleep phase), while activation during the biological morning delays it. This dual receptor mechanism explains why melatonin both promotes acute sleepiness and shifts circadian timing.

Beyond sleep, melatonin is one of the most potent endogenous antioxidants. It directly scavenges hydroxyl radicals, superoxide anions, hydrogen peroxide, and peroxynitrite through electron donation. Uniquely, melatonin's antioxidant cascade is amplified — its metabolites (cyclic 3-hydroxymelatonin, AFMK, AMK) are themselves antioxidants, so each melatonin molecule can neutralize up to 10 reactive oxygen species in a cascade. Melatonin also upregulates antioxidant enzymes (superoxide dismutase, glutathione peroxidase, catalase) and downregulates pro-oxidant enzymes (nitric oxide synthase, lipoxygenase). In the immune system, MT1 receptors on T helper cells, natural killer cells, and eosinophils modulate immune function — melatonin generally enhances Th1 cellular immunity, increases NK cell activity, and augments antibody responses to vaccination, which has led to interest in melatonin as an immunomodulator in aging and cancer.